Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19 - CNRS - Centre national de la recherche scientifique Access content directly
Preprints, Working Papers, ... Year :

Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19

Stuart Weisberg
  • Function : Author
Thomas Connors
  • Function : Author
Yun Zhu
  • Function : Author
Matthew Baldwin
  • Function : Author
Wen-Hsuan Lin
  • Function : Author
Sandeep Wontakal
  • Function : Author
Peter Szabo
  • Function : Author
Steven Wells
  • Function : Author
Pranay Dogra
  • Function : Author
Joshua Gray
  • Function : Author
Emma Idzikowski
  • Function : Author
Francesca Bovier
  • Function : Author
Julia Davis-Porada
  • Function : Author
Rei Matsumoto
  • Function : Author
Maya Meimei Li Poon
  • Function : Author
Michael Chait
  • Function : Author
Didier Decimo
  • Function : Author
Zachary Bitan
  • Function : Author
Francesca La Carpia
  • Function : Author
Stephen Ferrara
  • Function : Author
Emily Mace
  • Function : Author
Joshua Milner
Anne Moscona
Eldad Hod
  • Function : Author
Matteo Porotto
Donna Farber
  • Function : Author

Abstract

Clinical manifestations of COVID-19 caused by the novel coronavirus SARS-CoV-2 are associated with age. While children are largely spared from severe respiratory disease, they can present with a SARS-CoV-2-associated multisystem inflammatory syndrome (MIS-C) similar to Kawasaki's disease. Here, we show distinct antibody (Ab) responses in children with MIS-C compared to adults with severe COVID-19 causing acute respiratory distress syndrome (ARDS), and those who recovered from mild disease. There was a reduced breadth and specificity of anti-SARS-CoV-2-specific antibodies in MIS-C patients compared to the COVID patient groups; MIS-C predominantly generated IgG Abs specific for the Spike (S) protein but not for the nucleocapsid (N) protein, while both COVID-19 cohorts had anti-S IgG, IgM and IgA Abs, as well as anti-N IgG Abs. Moreover, MIS-C patients had reduced neutralizing activity compared to COVID-19 cohorts, indicating a reduced protective serological response. These results suggest a distinct infection course and immune response in children and adults who develop severe disease, with implications for optimizing treatments based on symptom and age.

Domains

Immunology
Fichier principal
Vignette du fichier
2020.07.12.20151068v1.full(1).pdf (1.3 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03010966 , version 1 (30-12-2020)

Identifiers

Cite

Stuart Weisberg, Thomas Connors, Yun Zhu, Matthew Baldwin, Wen-Hsuan Lin, et al.. Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19. 2020. ⟨hal-03010966⟩
207 View
224 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More